These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3223193)

  • 1. Drug addiction and pregnancy: a different perspective.
    Custo GM; Saitto C; Minozzi M
    Acta Eur Fertil; 1988; 19(2):105-6. PubMed ID: 3223193
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of biologic markers in epidemiologic studies of prenatal drug exposure: issues in study design.
    Bracken MB; Leaderer B; Belanger K
    NIDA Res Monogr; 1992; 117():41-60. PubMed ID: 1620210
    [No Abstract]   [Full Text] [Related]  

  • 3. Measurement of substance use during pregnancy: methodologic issues.
    Day NL; Wagener DK; Taylor PM
    NIDA Res Monogr; 1985; 59():36-47. PubMed ID: 3929131
    [No Abstract]   [Full Text] [Related]  

  • 4. The emergence of maternal drug addiction as a problem in Ireland 1981.
    Ryan A; Magee T; Johnson SS; Griffin E; Kelly MG
    Ir Med J; 1983 Feb; 76(2):86-9. PubMed ID: 6841026
    [No Abstract]   [Full Text] [Related]  

  • 5. Addiction and prenatal screening.
    Monroe L
    Am Fam Physician; 1988 Dec; 38(6):46. PubMed ID: 3195422
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug addiction in pregnancy and pregnancy outcome: a call for global solutions.
    Kuczkowski KM
    Subst Use Misuse; 2005; 40(11):1749-50. PubMed ID: 16253939
    [No Abstract]   [Full Text] [Related]  

  • 7. Measuring prenatal drug exposure.
    Bergin C; Cameron CE; Fleitz RS; Patel AV
    J Pediatr Nurs; 2001 Aug; 16(4):245-55. PubMed ID: 11498817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Substance abuse and toxicity. Fetal drug syndrome].
    Rodé M
    Orv Hetil; 2003 Aug; 144(32):1575-82. PubMed ID: 12974182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of the prevalence of drug misuse by meconium analysis.
    Williamson S; Jackson L; Skeoch C; Azzim G; Anderson R
    Arch Dis Child Fetal Neonatal Ed; 2006 Jul; 91(4):F291-2. PubMed ID: 16790733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pregnant adolescent and drugs.
    Schneider LE
    Semin Adolesc Med; 1986 Sep; 2(3):231-4. PubMed ID: 3496642
    [No Abstract]   [Full Text] [Related]  

  • 11. Perinatal addiction: the effects of maternal narcotic and nonnarcotic substance abuse on the fetus and neonate.
    Chasnoff IJ; Burns WJ; Schnoll SH
    NIDA Res Monogr; 1984 Mar; 49():220-6. PubMed ID: 6434963
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of perinatal substance abusers: experiences of one Perinatal-20 project.
    Haller DL; Ingersoll KS
    NIDA Res Monogr; 1996; 166():143-62. PubMed ID: 8818170
    [No Abstract]   [Full Text] [Related]  

  • 13. Meconium drug screening to detect prenatal substance abuse.
    Wildman KM; Mohl V; Houston R; Allerheiligen D
    J Fam Pract; 1996 Nov; 43(5):501-2. PubMed ID: 8917151
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel methods for the detection of drug and alcohol exposure during pregnancy: implications for maternal and child health.
    Koren G; Hutson J; Gareri J
    Clin Pharmacol Ther; 2008 Apr; 83(4):631-4. PubMed ID: 18288086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roadblocks to identifying drug use in pregnant women.
    Trute J
    J Am Diet Assoc; 1992 Jun; 92(6):676. PubMed ID: 1607561
    [No Abstract]   [Full Text] [Related]  

  • 16. Perinatal substance abuse and the drug-exposed neonate.
    Bennett AD
    Adv Nurse Pract; 1999 May; 7(5):32-6; quiz 37-8. PubMed ID: 10578732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal substance use in a Western urban community.
    Buchi KF; Varner MW
    West J Med; 1994 Nov; 161(5):483-6. PubMed ID: 7810126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance abuse in pregnant women: making improved detection a good clinical outcome.
    Araojo R; McCune S; Feibus K
    Clin Pharmacol Ther; 2008 Apr; 83(4):520-2. PubMed ID: 18349872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Universal screening for substance abuse at the time of parturition.
    Azadi A; Dildy GA
    Am J Obstet Gynecol; 2008 May; 198(5):e30-2. PubMed ID: 18279831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [How to diagnose pregnant women with drug abuse problems and which ones need support].
    Ottenblad C
    Jordemodern; 1992; 105(7-8):236-9, 242. PubMed ID: 1634385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.